MetaCap

InnovAge Holding Corp. (INNV)

NASDAQ: INNVHealth CareMedical/Nursing ServicesUSD

9.16+0.25 (+2.81%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

INNV stock chart

Technical analysis

Key statistics

All statistics
P/E (TTM)
152.67
52-week range
4.70 – 12.64
Day range
8.84 – 9.22
Volume / Avg
498.36K / 595.71K
Beta
—

52-week range

$4.70$12.64

INNV stock today

Shares of InnovAge (INNV) finished higher on Nov 20 at $9.16, a gain of 2.81% or $0.25 per share, versus the S&P 500's 3.70% decline. Shares are 27.5% below their 52-week high of $12.64, set on Jun 30, 2026 and 94.9% above the 52-week low of $4.70, in the middle of the past year's range. INNV is up 76.5% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 74.5%.

At 152.7x trailing earnings, InnovAge trades above the peer-group median of 29.7x. Its forward P/E of 18.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About InnovAge

Company profile

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach.

Industry
Medical/Nursing Services
CEO
Mr. Patrick Blair
Headquarters
Denver, CO
Employees
2,500
IPO year
2021

Financial highlights

Full financials

In fiscal 2026, InnovAge generated $989.7 million in revenue, up 15.9% from fiscal 2025, its 3rd consecutive year of revenue growth. InnovAge reported a net loss of $2.5 million, compared with a loss of $30.3 million a year earlier. Gross margin was 23.0% (up from 18.0%) and operating margin 0.3%.

InnovAge annual revenue, net income and EPS
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue$989.71M$853.70M$763.86M$688.09M$698.64M
Growth+15.93%+11.76%+11.01%-1.51%+9.54%
Net income$-2.54M$-30.31M$-21.34M$-40.67M$-6.52M
EPS (diluted)$-0.02$-0.22$-0.16$-0.30$-0.05

Analyst forecast

Forecast

Consensus (3 analysts)

none

Avg. price target

$12.00+31.00%

  • Strong buy 0
  • Buy 1
  • Hold 1
  • Sell 0
  • Strong sell 1

Target range

Low $10.00High $14.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 3, 2026
EPS actual vs est.
$0.14 vs $0.11
Surprise
+27.27%

INNV news

All INNV news

InnovAge peers

Health Care sector
INNV peer companies
CompanyPrice% ChgMarket capCompare
PNTGThe Pennant Group Inc.34.64+1.61%$1.22Bvs INNV
TDOCTeladoc Health Inc.7.45-4.36%$1.36Bvs INNV
WGSGeneDx Holdings Corp. Class A45.46-7.68%$1.36Bvs INNV
USPHU.S. Physical Therapy Inc.95.93+1.71%$1.43Bvs INNV
AHCOAdaptHealth Corp.7.20-0.69%$982.98Mvs INNV
OMDAOmada Health Inc.11.87-5.04%$736.39Mvs INNV
SBCSBC Medical Group Holdings Incorporated5.17-7.68%$530.32Mvs INNV
SRTAStrata Critical Medical Inc. Class A4.56-5.59%$407.30Mvs INNV

Indexes, lists and sector

InnovAge stock FAQ

What is InnovAge's stock price today?

INNV last traded at $9.16 as of Nov 20, 4:00 PM EST, up 2.81% on the day. Prices are delayed at least 15 minutes.

What is INNV's P/E ratio?

INNV trades at a trailing P/E ratio of 152.67 and a forward P/E of 18.32, compared with a median of 29.7 for its closest peers.

Who is InnovAge's CEO?

Mr. Patrick Blair is the chief executive officer of InnovAge Holding Corp., which has about 2,500 employees.

What is the INNV 52-week high?

The 52-week high for INNV is $12.64 and the 52-week low is $4.70. The stock is currently 27.5% below its high.

Compare INNV